The TSX Venture Exchange has accepted for filing a stock purchase agreement dated Jan. 19, 2017, between LED Medical Diagnostics Inc., and Apteryx Inc. and Kevin M. Crucs, whereby the company may acquire 100 per cent of the shares of Apteryx and certain associated intellectual property. Consideration is $8-million (U.S.) cash and 42,323,000 common shares payable over two years.
© 2024 Canjex Publishing Ltd. All rights reserved.